Corrigendum to “The discovery of a structurally novel class of inhibitors of the type 1glycine transporter” [Bioorg. Med. Chem. Lett. 19 (2009) 2974]

Corrigendum to “The discovery of a structurally novel class of inhibitors of the type 1glycine transporter” [Bioorg. Med. Chem. Lett. 19 (2009) 2974]

Bioorganic & Medicinal Chemistry Letters 19 (2009) 4885 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal h...

102KB Sizes 0 Downloads 98 Views

Bioorganic & Medicinal Chemistry Letters 19 (2009) 4885

Contents lists available at ScienceDirect

Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl

Corrigendum

Corrigendum to ‘‘The discovery of a structurally novel class of inhibitors of the type 1glycine transporter” [Bioorg. Med. Chem. Lett. 19 (2009) 2974] John A. Lowe III *, Xinjun Hou, Christopher Schmidt, F. David Tingley III, Stan McHardy  , Monica Kalman, Shari DeNinno, Mark Sanner, Karen Ward, Lorraine Lebel, Don Tunucci, James Valentine, Brian S. Bronk, Eric Schaeffer Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, United States

The names of Brian S. Bronk and Eric Schaeffer were inadvertently omitted from the author line. The corrected author line appears above.

DOI of original article: 10.1016/j.bmcl.2009.04.035 * Corresponding author. Address: 28 Coveside Lane, Stonington, CT 06378, United States. Tel.: +1 860 535 4283. E-mail address: [email protected] (J.A. Lowe III).   Present address: Southwest Research Institute, San Antonio, TX 78228, United States. 0960-894X/$ - see front matter Ó 2009 Elsevier Ltd. All rights reserved. doi:10.1016/j.bmcl.2009.06.068